Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?

Detalles Bibliográficos
Autores principales: Trifirò, Gianluca, Crisafulli, Salvatore, Andò, Giuseppe, Racagni, Giorgio, Drago, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164333/
https://www.ncbi.nlm.nih.gov/pubmed/32303915
http://dx.doi.org/10.1007/s40264-020-00935-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164333/
https://www.ncbi.nlm.nih.gov/pubmed/32303915
http://dx.doi.org/10.1007/s40264-020-00935-2

Ejemplares similares